OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible?
Yolanda M. Jacobo-Delgado, Adrián Rodríguez-Carlos, Carmen J. Serrano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24

Showing 24 citing articles:

New Frontiers in Fighting Mycobacterial Infections: Venom-Derived Peptides
Hamed Memariani, Mojtaba Memariani
Probiotics and Antimicrobial Proteins (2025)
Closed Access

Decoding the Role of Antimicrobial Peptides in the Fight against Mycobacterium tuberculosis
Sapna Saini, Soma Pal, Rashmi Sharma
ACS Infectious Diseases (2025)
Closed Access

Failure or future? Exploring alternative antibacterials: a comparative analysis of antibiotics and naturally derived biopolymers
Artemijs Ščeglovs, Ingus Skadiņš, Marco Chittò, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access

Tuberculosis Prevention, Diagnosis, and Treatment Financial Profile during 2006–2021: Part B
Nahid Madadi-Goli, Kamal Ahmadi, Maryam Meskini, et al.
Journal of Preventive Diagnostic and Treatment Strategies in Medicine (2024) Vol. 3, Iss. 1, pp. 37-43
Open Access | Times Cited: 5

Modulators targeting protein-protein interactions in Mycobacterium tuberculosis
Guo‐Feng Luo, Tianqi Ming, Yang Luchuan, et al.
Microbiological Research (2024) Vol. 284, pp. 127675-127675
Closed Access | Times Cited: 3

Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
Dian Ayu Eka Pitaloka, Yolani Syaputri, Puspita Nurlilasari, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1969-1979
Open Access | Times Cited: 3

Temperature-Induced Restructuring of Mycolic Acid Bilayers Modeling the Mycobacterium tuberculosis Outer Membrane: A Molecular Dynamics Study
Alexander V. Vasyankin, С. В. Пантелеев, Ilya S. Steshin, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 696-696
Open Access | Times Cited: 2

ERK1/2-CEBPB Axis-Regulated hBD1 Enhances Anti-Tuberculosis Capacity in Alveolar Type II Epithelial Cells
Yaoxin Chen, Zhenyu Han, Sian Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2408-2408
Open Access | Times Cited: 2

Application of BactTiter-Glo ATP bioluminescence assay for Mycobacterium tuberculosis detection
Mariana Abou Mourad Ferreira, Laura Candeias dos Santos, Luiz Guilherme Schmidt Castellani, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 109, Iss. 2, pp. 116275-116275
Closed Access | Times Cited: 2

Depletion of essential mycobacterial gene glmM reduces pathogen survival and induces host-protective immune responses against tuberculosis
Meetu Agarwal, Ashima Bhaskar, Biplab Singha, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Mycobacterium tuberculosis and its clever approaches to escape the deadly macrophage
Vinaya Krishnan, Sreemoye Nath, Preetha Nair, et al.
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 11
Closed Access | Times Cited: 3

Defensins: A novel weapon against Mycobacterium tuberculosis?
Xuehan Gao, Jihong Feng, Linna Wei, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111383-111383
Closed Access | Times Cited: 2

Polymer-Based Nanomaterials Against Multidrug-Resistant Bacteria
Ana R. M. Ribeiro, Marta O. Teixeira, Elina Marinho, et al.
(2024), pp. 251-289
Closed Access

Searching for Chemical Agents Suppressing Substrate Microbiota in White-Rot Fungi Large-Scale Cultivation
Audrius Maruška, Rūta Mickienė, Vilma Kaškonienė, et al.
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1242-1242
Open Access

Enhanced Antimicrobial Peptide Response Following Bacillus Calmette–Guerin Vaccination in Elderly Individuals
Arul Nancy Pandiarajan, Nathella Pavan Kumar, Anuradha Rajamanickam, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1065-1065
Open Access

New avenues in the age old battle against TB
Morgan Morris
Nature Africa (2024)
Closed Access

De nouvelles pistes dans la lutte contre la tuberculose
Morgan Morris
Nature Africa (2024)
Closed Access

Differential Host Gene Expression in Response to Infection by Different Mycobacterium tuberculosis Strains—A Pilot Study
Dewi Megawati, Lisa Y. Armitige, Loubna Tazi
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2146-2146
Open Access

Bacterial Antimicrobial Peptides: A Potential Alternative to Antibiotics
Sumeeta Kumari, Alka Kumari
(2024), pp. 23-53
Closed Access

Identification of novel fructose 1,6-bisphosphate aldolase inhibitors against tuberculosis: QSAR, molecular docking, and molecular dynamics simulation-based analysis of DrugBank compounds
Sree Bhushan Raju, Kasi Murugan, Mahesha Nand, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access

The <em>Mycobacterium tuberculosis</em>: A Silent Killer
Heloisa Veríssimo de Oliveira, Joiciane Ferreira, Ana Carolina Matta, et al.
(2023)
Open Access | Times Cited: 1

Page 1

Scroll to top